When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRTX - Mirati up 32% on Amgen's KRAS inhibitor data
Mirati Therapeutics Inc.
Mirati Therapeutics (MRTX+32.4%) is up on over 40% higher volume in apparent response to Phase 1 data on Amgen's KRASG12C inhibitor AMG 510 presented at ASCO in Chicago.
More news on: Mirati Therapeutics, Inc., Healthcare stocks news, Stocks on the move,